CD3E - CD3e molecule Gene

Species: Macaca fascicularis

Gene Type: protein coding
Gene ID: 102133065

CD3E Products (2)

mRNA Protein Name
XM_015435353.2 XP_015290839.2 T-cell surface glycoprotein CD3 epsilon chain isoform X2
XM_015435352.2 XP_015290838.2 T-cell surface glycoprotein CD3 epsilon chain isoform X1
Protein Preferred Names Protein Names

T-cell surface glycoprotein CD3 epsilon chain

  • CD3 epsilon FN18+

  • CD3 epsilon FN18-

  • CD3e molecule, epsilon (CD3-TCR complex)

Recombinant CD3E Proteins

Cat. No. Product Name Accession Purity
HY-P70090 CD3 epsilon Protein, Cynomolgus (HEK293, Fc) Q95LI5 (Q22-D117) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P72727 CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc-Flag&Fc-His) Q95LI8 (F22-A105)&Q95LI5 (Q22-D117) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P77603 CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc) Q95LI8 (F22-A105)&Q95LI5 (Q22-D117) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P77604 CD3D-CD3E Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc) Q95LI8 (F22-A105)&Q95LI5 (Q22-D117) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P77605 CD3E-CD3G Heterodimer Protein, Cynomolgus (HEK293, Fc) Q95LI5 (Q22-D117)&Q95LI7 (Q23-T113) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P77606 CD3E-CD3G Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc) Q95LI5 (Q22-D117)&Q95LI7 (Q23-T113) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P77607 CD3 epsilon 1-27 peptide Protein, Cynomolgus (HEK293, Fc-Avi) Q95LI5 (D22-T48) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P77608 CD3 epsilon 1-27 peptide Protein, Cynomolgus (Biotinylated, HEK293, Fc-Avi) Q95LI5 (D22-T48) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P78269 CD3 epsilon Protein, Cynomolgus (HEK293, His) Q95LI5 (Q22-D117) ≥ 95%, as determined by Bis-Tris PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive MoleculesInhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9963 Blinatumomab Inhibitor 98.78% Unkown
HY-P99909 Elranatamab 98.74% Unkown

Clinical Phase

Bioactive MoleculesInhibitory Antibodies (12)
Cat. No. Product Name Effect
Purity Phase
HY-P990932 Obrixtamig Inhibitor 99.9% Phase 3
HY-P99332 Visilizumab Inducer 98.48% Phase 3
HY-P990920 Gocatamig Inhibitor ≥99.0% Phase 2
HY-P990953 Zubotamig Inhibitor 96.46% Phase 2
HY-P99914 Emfizatamab Activator 95.495% Phase 2
HY-P991708 Olsutamig Inhibitor 99.00% Phase 2
HY-P99868 Duvortuxizumab ≥99.0% Phase 1
HY-P99798 Pacanalotamab Chemical 97.04% Phase 1
HY-P990692 Ciduvectamig Inhibitor 95.879% Phase 1
HY-P991671 Anafiltamig Inhibitor / Phase 1
HY-P991681 Emaretamig Inhibitor 97.96% Phase 1
HY-P991469 AMG-211 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (3)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS02243 CD3E Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17021 Cd3e Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23464 Cd3e Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Bioactive MoleculesInhibitory Antibodies (17)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P99896 Runimotamab 99.00% Unkown
HY-P990903 Avitotamig Inhibitor 95.98% Unkown
HY-P991706 Nelvutamig Inhibitor 97.76% Unkown
HY-P991034 Trevotamig Inhibitor 95.539% Unkown
HY-P990714 Obertamig Inhibitor 95.803% Unkown
HY-P991461 AMG-424 Inhibitor 99.32% Unkown
HY-P990939 Podentamig Inhibitor / Unkown
HY-P991686 Gamgertamig Inhibitor 99.32% Unkown
HY-P992136 Torutamig Inhibitor / Unkown
HY-P992145 Zeclantamig / Unkown
HY-P990698 Umizortamig / Unkown
HY-P991700 Lumivatamig Inhibitor 97.24% Unkown
HY-P992140 Varzutamig Inhibitor / Unkown
HY-P991463 MS133 Inhibitor / Unkown
HY-P991552 AFM15 Inducer / Unkown
HY-P992061 Anti-Mouse CD3E Antibody (500A2) / Unkown
HY-P992370 HPN601 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CD3E NCBI NCBI:916
Canis familiaris CD3E NCBI NCBI:442981
Mus musculus CD3E NCBI NCBI:12501
Rattus norvegicus CD3E NCBI NCBI:315609
Macaca mulatta CD3E NCBI NCBI:699467